Divi’s Laboratories Limited has recently informed exchanges that the company officially commenced commercial operations at part of Phase I of its Unit III greenfield project located in Ontimamidi Village, Kakinada, Andhra Pradesh, as of January 1, 2025. This milestone is a key development in the company’s ongoing expansion efforts.
The Unit III project is being developed on a 200-acre portion of the total 500-acre site, with an estimated investment ranging between ₹1,200 crores and ₹1,500 crores.
Due to delays in receiving final confirmation of commencement, the announcement is being made on January 2, 2025. The company looks forward to further progress in the coming months.
In the meantime, Divi’s Laboratories shares opened at ₹6,073.00, reaching a high of ₹6,154.75 and a low of ₹6,010.00. The stock has shown strong performance, with a 52-week high of ₹6,285.45 and a 52-week low of ₹3,350.00.
